Back to top
more

Abbott Laboratories (ABT)

(Delayed Data from NYSE)

$119.39 USD

119.39
6,741,790

+1.50 (1.27%)

Updated Oct 18, 2024 04:00 PM ET

After-Market: $119.40 +0.01 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (72 out of 250)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Abbott (ABT) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

In the latest trading session, Abbott (ABT) closed at $106.21, marking a -1.93% move from the previous day.

Earnings Preview: Abbott (ABT) Q2 Earnings Expected to Decline

by Zacks Equity Research

Abbott (ABT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

by Zacks Equity Research

Sector ETF report for IHI

Abbott (ABT) Gains But Lags Market: What You Should Know

by Zacks Equity Research

Abbott (ABT) closed at $109.49 in the latest trading session, marking a +0.74% move from the prior day.

The Zacks Analyst Blog Highlights Abbott, T-Mobile US, Intuit, Analog Devices and The Progressive

by Zacks Equity Research

Abbott, T-Mobile US, Intuit, Analog Devices and The Progressive are part of Zacks top Analyst Blog.

Abbott (ABT) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Abbott (ABT) closed at $110.22 in the latest trading session, marking a +1.45% move from the prior day.

Mark Vickery headshot

Top Stock Reports for Abbott Laboratories, T-Mobile & Intuit

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), T-Mobile US, Inc. (TMUS) and Intuit Inc. (INTU).

Abbott (ABT) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Abbott (ABT) closed the most recent trading day at $109.10, moving +1.99% from the previous trading session.

ESLOY or ABT: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

ESLOY vs. ABT: Which Stock Is the Better Value Option?

Strength Seen in Abbott (ABT): Can Its 3.1% Jump Turn into More Strength?

by Zacks Equity Research

Abbott (ABT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Abbott (ABT) Gains But Lags Market: What You Should Know

by Zacks Equity Research

In the latest trading session, Abbott (ABT) closed at $106.21, marking a +0.73% move from the previous day.

Abbott (ABT) Gains But Lags Market: What You Should Know

by Zacks Equity Research

In the latest trading session, Abbott (ABT) closed at $104.41, marking a +1.83% move from the previous day.

Abbott (ABT) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, Abbott (ABT) closed at $104.80, marking a +1.81% move from the previous day.

ESLOY vs. ABT: Which Stock Is the Better Value Option?

by Zacks Equity Research

ESLOY vs. ABT: Which Stock Is the Better Value Option?

Abbott (ABT) Medical Devices Arm Gains Traction, FX Woe Stays

by Zacks Equity Research

Within Abbott's (ABT) Nutrition arm, while the pediatric nutrition business witnesses a drag, the adult nutrition business continues to perform well.

The Zacks Analyst Blog Highlights Novo Nordisk, Toyota Motor, Salesforce, Abbott Laboratories, Raytheon Technologies, and Equinor

by Zacks Equity Research

Novo Nordisk, Toyota Motor, Salesforce, Abbott Laboratories, Raytheon Technologies, and Equinor are part of Zacks top Analyst Blog.

Abbott (ABT) Stock Moves -1.73%: What You Should Know

by Zacks Equity Research

In the latest trading session, Abbott (ABT) closed at $112.71, marking a -1.73% move from the previous day.

Sheraz Mian headshot

Top Research Reports for Novo Nordisk, Toyota & Salesforce

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), Toyota Motor Corporation (TM), and Salesforce, Inc. (CRM).

Abbott (ABT) FreeStyle Libre 3 System's Study Outcome Favorable

by Zacks Equity Research

Abbott's (ABT) FreeStyle Libre 3 system is the first and only 14-day CGM system with an overall MARD of 7.9%.

Abbott (ABT) Stock Moves -0.8%: What You Should Know

by Zacks Equity Research

Abbott (ABT) closed the most recent trading day at $116.57, moving -0.8% from the previous trading session.

Cardiovascular Systems (CSII) Up 0.9% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Cardiovascular Systems (CSII) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Abbott (ABT) Receives FDA Nod for FreeStyle Libre 3 System

by Zacks Equity Research

Abbott's (ABT) FreeStyle Libre 3 system offers greater accuracy and easier application compared with other CGMs.

ESLOY vs. ABT: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

ESLOY vs. ABT: Which Stock Is the Better Value Option?

Abbott (ABT) to Commence Limited Release of EleCare Soon

by Zacks Equity Research

Abbott's (ABT) release of limited quantities of EleCare branded specialty formulas to be free of charge to children in need.

Abbott (ABT) Transcatheter Valve Devices' Study Data Favorable

by Zacks Equity Research

Abbott's (ABT) study data presented at EuroPCR 2022 reinforces the company's commitment to offering structural heart solutions, supported by clinical evidence that exceeds existing standards of care.